Tsung Jamie
Director Alnylam
Jamie Tsung is a CMC and drug development expert with extensive experience in product development , regulatory strategy, and CMC development for small molecules, nucleic acids, and biologics. She has led programs from early development through commercialization, held key roles at UCB, Baxter, Shire, Momenta, and Alnylam, and is passionate about advancing innovative medicines and mentoring future scientific leaders.
Seminars
As the brain and muscle remain key targets for LNP drug products, this workshop will explore the hurdles of the blood-brain barrier and broad muscle biodistribution. Gain insights and have proactive discussions into how to optimize LNP formulations to achieve efficient, specific and selective delivery to muscle and CNS targets. Topics include:
- Examining how to fine-tune LNP characteristics to enable efficient delivery across extensive muscle areas without compromising immunogenicity
- Uncovering ligand approaches for achieving selective LNP penetration across the blood–brain barrier
- Evaluating how dual-targeting strategies may navigate endothelial barriers to deliver payloads into muscle and brain
